Infield uses patient data to predict the largest adherence challenges patients may face before and after a hospital visit.
Based on that analysis, each patient receives an custom care plan on his or her mobile phone.
As patients move through their plan, two-way communication improves guidance and outcomes.
Handles business and technology development.
Previously, Doug was a scientist at Vertex Pharmaceuticals in Cambridge, Massachusetts. He was on a team that led to the creation of an FDA-approved treatment for Hepatitis C: Incivek (telaprevir). In addition, he is a co-inventor of pre-clinical compounds related to immunosuppression and psoriasis. Doug was also involved in healthcare finance at the National Cooperative Bank in Washington DC
Handles content development and new provider rollout.
Alison is CPH and CHES certified, serves as a Spanish medical interpreter for global health care missions, and is a faculty member of The University of Colorado.
Handles patient and adherence data modeling.
Kunal has led projects in healthcare data analytics for the Centers for Medicare and Medicaid Services, Sanofi Adventis and several other healthcare firms. He's also led projects in the banking and insurance sectors. Kunal earned a BS in Industrial Management from Carnegie Mellon University.
Infield's mission is to help informed patients get better, faster while reducing the total cost of care. In five years we've delivered health information to over 20,000 people directly on their mobile phones. Infield projects have been published in major medical journals and have supported three randomized controlled trials.
1133 15th Street, NW.
Washington DC 20005